RETRACTION: Oxaliplatin Activates P53/miR-34a/Survivin Axis in Inhibiting the Progression of Gastric Cancer Cells

IF 3.1 4区 医学 Q3 IMMUNOLOGY
{"title":"RETRACTION: Oxaliplatin Activates P53/miR-34a/Survivin Axis in Inhibiting the Progression of Gastric Cancer Cells","authors":"","doi":"10.1002/iid3.70191","DOIUrl":null,"url":null,"abstract":"<p><b>RETRACTION</b>: Q. Guo, X.-Y. Wang, Y.-C. Zhai, Y.-W. Dong, and Q.-S. He, “Oxaliplatin Activates P53/miR-34a/Survivin Axis in Inhibiting the Progression of Gastric Cancer Cells,” <i>Immunity, Inflammation and Disease</i> 12, no. 9 (2024): e70004, https://doi.org/10.1002/iid3.70004.</p><p>The above article, published online on 10 September 2024 in Wiley Online Library (wileyonlinelibrary.com), has been retracted by agreement between the journal Editor-in-Chief, Marc Veldhoen; and John Wiley &amp; Sons Ltd. The retraction has been agreed upon due to insufficient information included within the methodology, which prevents accurate reproduction of the study. Furthermore, there are concerns that the beta actin bands included in Figure 3a do not originate from the same gel as the other bands shown in this figure. Finally, the cell line used in this study was reported to be contaminated. The authors were contacted for comment and supporting data, but they did not respond. The editors consider the results and conclusions unreliable. The authors were informed of the retraction.</p>","PeriodicalId":13289,"journal":{"name":"Immunity, Inflammation and Disease","volume":"13 4","pages":""},"PeriodicalIF":3.1000,"publicationDate":"2025-04-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1002/iid3.70191","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Immunity, Inflammation and Disease","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/iid3.70191","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"IMMUNOLOGY","Score":null,"Total":0}
引用次数: 0

Abstract

RETRACTION: Q. Guo, X.-Y. Wang, Y.-C. Zhai, Y.-W. Dong, and Q.-S. He, “Oxaliplatin Activates P53/miR-34a/Survivin Axis in Inhibiting the Progression of Gastric Cancer Cells,” Immunity, Inflammation and Disease 12, no. 9 (2024): e70004, https://doi.org/10.1002/iid3.70004.

The above article, published online on 10 September 2024 in Wiley Online Library (wileyonlinelibrary.com), has been retracted by agreement between the journal Editor-in-Chief, Marc Veldhoen; and John Wiley & Sons Ltd. The retraction has been agreed upon due to insufficient information included within the methodology, which prevents accurate reproduction of the study. Furthermore, there are concerns that the beta actin bands included in Figure 3a do not originate from the same gel as the other bands shown in this figure. Finally, the cell line used in this study was reported to be contaminated. The authors were contacted for comment and supporting data, but they did not respond. The editors consider the results and conclusions unreliable. The authors were informed of the retraction.

撤回:奥沙利铂激活P53/miR-34a/Survivin轴抑制胃癌细胞进展
撤稿:郭强,小银。王,研究。翟,Y.-W。Dong和q - s。He,“奥沙利铂激活P53/miR-34a/Survivin轴在抑制胃癌细胞进展中的作用”,免疫,炎症与疾病12,no. 1。9 (2024): e70004, https://doi.org/10.1002/iid3.70004.The上述文章于2024年9月10日在线发表在Wiley在线图书馆(wileyonlinelibrary.com)上,经期刊主编Marc Veldhoen同意撤回;约翰·威利&;子有限公司由于方法中包含的信息不足,这妨碍了研究的准确复制,因此已同意撤回。此外,还有人担心图3a中包含的β肌动蛋白带与图中显示的其他带并非来自同一种凝胶。最后,据报道,本研究中使用的细胞系受到了污染。记者联系了作者,要求他们发表评论和提供支持数据,但他们没有回应。编辑认为结果和结论不可靠。作者被告知撤稿。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Immunity, Inflammation and Disease
Immunity, Inflammation and Disease Medicine-Immunology and Allergy
CiteScore
3.60
自引率
0.00%
发文量
146
审稿时长
8 weeks
期刊介绍: Immunity, Inflammation and Disease is a peer-reviewed, open access, interdisciplinary journal providing rapid publication of research across the broad field of immunology. Immunity, Inflammation and Disease gives rapid consideration to papers in all areas of clinical and basic research. The journal is indexed in Medline and the Science Citation Index Expanded (part of Web of Science), among others. It welcomes original work that enhances the understanding of immunology in areas including: • cellular and molecular immunology • clinical immunology • allergy • immunochemistry • immunogenetics • immune signalling • immune development • imaging • mathematical modelling • autoimmunity • transplantation immunology • cancer immunology
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信